DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

Incyte Corp (NASDAQ: INCY)

104.25 -4.29 (-3.95%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INCY $104.25 -3.95%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.00
Previous Close $108.54
Daily Range $103.73 - $108.13
52-Week Range $43.86 - $121.70
Market Cap $18.7B
P/E Ratio -571.26
Dividend (Yield) $0.00 (0.0%)
Volume 1,398,563
Average Daily Volume 910,237
Current FY EPS -$0.30

Sector

Healthcare

Industry

Drug Makers

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website: http://www.incyte.com/

News & Commentary Rss Feed

Cancer Drugs: 2 Stocks to Watch

AstraZeneca and Agenus Inc. are paving the way for a new generation of breakthrough cancer drugs that boost the immune system's ability to detect and eradicate malignancies. Here's what investors need to know about these two biopharmas going forward.

First Week of INCY March 2016 Options Trading

Analysts Break Down Impact Of $7.2B Receptos Buyout

New Strong Sell Stocks for July 13th - Tale of the Tape

3 Stocks Boosting The Health Care Sector Higher

Immunovaccine Collaborates With Incyte to Evaluate Novel Immunotherapy Combination for Patients With

Immunovaccine Collaborates With Incyte to Evaluate Novel Immunotherapy Combination for Patients With Platinum-Sensitive Ovarian Cancer

Agenus Gets Billion-Dollar Valuation From Analyst Based on Cancer Drug That Doesn't Exist

The Best Pairs Trade In The Market: Buy Geron And Short Incyte

High Time To Go Short Incyte Pharmaceuticals

JMP Sees A 'Negative Market Tone' In Biotechnology

Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in rheumatoid arthritis

See More INCY News...

INCY's Top Competitors

INCY $104.25 (-3.95%)
Current stock: INCY
AMGN $165.54 (4.38%)
Current stock: AMGN
CELG $132.56 (-1.73%)
Current stock: CELG
BIIB $309.43 (3.13%)
Current stock: BIIB